Spinal cord atrophy and myelomalacia following triple intrathecal chemotherapy in a patient of relapsed acute lymphoblastic leukemia

Authors

  • Sheesham Agrawal
  • Pawan Kumar Sulaniya
  • Kapil Garg
  • S Sitaraman
  • Chandrakanta Sulaniya

DOI:

https://doi.org/10.32677/IJCH.2017.v04.i01.025

Keywords:

Acute lymphoblastic leukemia, Intrathecal therapy, Methotrexate, Myelomalacia, Relapse

Abstract

Paraplegia in a case of leukemia is an uncommon finding. It can be disease related, therapy related, or both. It may or may not be reversible or curable. Here, we are discussing an unusual acute life-threatening, therapy related condition, where triple intrathecal therapy in a relapsed acute lymphoblastic leukemia child led to severe spinal cord atrophy and myelomalacia causing acute paraplegia with urinary retention. Subsequently, the patient developed respiratory failure and succumbed to death. There is very few case reported of this complication. The aim of this case report is to sensitize, the pediatricians and pediatric oncologists about this life-threatening complication of chemotherapy.

Downloads

Download data is not yet available.

Downloads

Published

2017-03-28

Issue

Section

Case Reports

How to Cite

Spinal cord atrophy and myelomalacia following triple intrathecal chemotherapy in a patient of relapsed acute lymphoblastic leukemia. (2017). Indian Journal of Child Health, 4(1), 98-99. https://doi.org/10.32677/IJCH.2017.v04.i01.025